Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 2
1990 1
1991 2
1992 1
1993 2
1996 1
1997 1
1998 2
1999 2
2000 2
2001 2
2002 5
2003 2
2004 4
2005 1
2006 4
2007 2
2008 4
2009 3
2010 4
2011 5
2012 1
2014 2
2015 5
2016 1
2017 1
2018 7
2019 5
2020 5
2021 8
2022 10
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
Syphilis, unusual cause of abdominal pain.
Navea C, von Mühlenbrock C, Cabello N, Echeverría M, Jiménez A, Poniachik J. Navea C, et al. Among authors: poniachik j. Gastroenterol Hepatol. 2018 Nov;41(9):565-566. doi: 10.1016/j.gastrohep.2017.11.009. Epub 2018 Jan 6. Gastroenterol Hepatol. 2018. PMID: 29317085 Review. English, Spanish. No abstract available.
The immune response as a therapeutic target in non-alcoholic fatty liver disease.
Ortiz-López N, Fuenzalida C, Dufeu MS, Pinto-León A, Escobar A, Poniachik J, Roblero JP, Valenzuela-Pérez L, Beltrán CJ. Ortiz-López N, et al. Among authors: poniachik j. Front Immunol. 2022 Oct 10;13:954869. doi: 10.3389/fimmu.2022.954869. eCollection 2022. Front Immunol. 2022. PMID: 36300120 Free PMC article. Review.
[Fulminant hepatic failure].
Poniachik J, Quera R, Lui A. Poniachik J, et al. Rev Med Chil. 2002 Jun;130(6):691-8. Rev Med Chil. 2002. PMID: 12194694 Review. Spanish.
Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.
Arab JP, Candia R, Zapata R, Muñoz C, Arancibia JP, Poniachik J, Soza A, Fuster F, Brahm J, Sanhueza E, Contreras J, Cuellar MC, Arrese M, Riquelme A. Arab JP, et al. Among authors: poniachik j. World J Gastroenterol. 2014 Sep 14;20(34):12182-201. doi: 10.3748/wjg.v20.i34.12182. World J Gastroenterol. 2014. PMID: 25232252 Free PMC article. Review.
[Primary biliary cholangitis. Experience in 179 patients].
Ramírez F, Urzúa Á, Roblero JP, Cattaneo M, Hurtado C, Poniachik J. Ramírez F, et al. Among authors: poniachik j. Rev Med Chil. 2022 Jul;150(7):889-895. doi: 10.4067/s0034-98872022000700889. Rev Med Chil. 2022. PMID: 37906822 Free article. Spanish.
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Zazueta A, Valenzuela-Pérez L, Ortiz-López N, Pinto-León A, Torres V, Guiñez D, Aliaga N, Merino P, Sandoval A, Covarrubias N, Pérez de Arce E, Cattaneo M, Urzúa A, Roblero JP, Poniachik J, Gotteland M, Magne F, Beltrán CJ. Zazueta A, et al. Among authors: poniachik j. Int J Mol Sci. 2024 Apr 16;25(8):4387. doi: 10.3390/ijms25084387. Int J Mol Sci. 2024. PMID: 38673972 Free PMC article.
96 results